ANDA 74549, held by Hospira. Ketamine Hydrochloride.
As of Nov 16, 2026, ANDA 74549 (Ketamine Hydrochloride), held by Hospira, was first approved by FDA on Jun 27, 1996, with 10 approved supplements and 0 published complete response letters.
Ketamine Hydrochloride Injection is indicated:
| Date | Submission | Status | Documents |
|---|---|---|---|
| Jun 27, 1996 | Original application | Approved | None posted |
| Ketamine HydrochlorideEQ 50MG BASE/ML · injectable;injection | Ketamine Hydrochloride | Rx |
| Ketamine HydrochlorideEQ 100MG BASE/ML · injectable;injection | Ketamine Hydrochloride | Rx |
| Apr 12, 2023 | Supplement 31Labeling · Standard review | Approved | None posted |
| Jul 19, 2021 | Supplement 28Labeling · Standard review | Approved | None posted |
| Apr 28, 2020 | Supplement 19Labeling · Standard review | Approved | None posted |
| Nov 7, 2017 | Supplement 18Labeling · Standard review | Approved | None posted |
| Jun 13, 2013 | Supplement 15Labeling · Standard review | Approved | None posted |
| Aug 10, 2004 | Supplement 7Labeling | Approved | None posted |
| Nov 24, 2003 | Supplement 4Labeling | Approved | None posted |
| Feb 14, 2001 | Supplement 3Manufacturing | Approved | None posted |
| Dec 13, 1999 | Supplement 2Labeling | Approved | None posted |
| Aug 24, 1999 | Supplement 1Labeling | Approved | None posted |
| Jun 27, 1996 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters